Global patient study identifies key reasons driving nonadherence to self-administered cancer medications
Atlantis Health, a leading global patient agency specializing in the latest behavioral science, today announced the key findings of the Atlantis Health Global Oncology Patient Nonadherence Study, which provides several new insights including reasons why people living with cancer consciously choose not to take their primary self-administered medication as prescribed.